膝關節腫脹治療市場規模、佔有率、成長分析（按類型、按藥物療法、按手術、按最終用戶、按地區）- 行業預測 2025-2032

2023 年膝蓋腫脹治療市場規模價值 20.9 億美元，預計將從 2024 年的 21.8 億美元成長到 2032 年的 31.1 億美元，預測期內（2025-2032 年）的複合年成長率為 4.5%。

由於非手術醫療保健解決方案的趨勢日益突出，膝蓋腫脹治療市場可能面臨成長挑戰。與傳統手術方案相比，患者越來越傾向於治療和準備治療，這標誌著微創和非侵入性方法的轉變。人們對包括膝關節關節重建在內的外科治療的潛在副作用和併發症的認知不斷提高，這正在推動患者偏好的轉變。隨著人們對手術風險的了解越來越多，他們積極尋找侵入性較小、恢復時間更快且仍能提供類似效果的替代方法。這種不斷變化的情況要求重新評估行銷策略，以符合患者對更安全、更保守的治療方法的偏好。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

膝關節腫脹治療市場規模（按類型及複合年成長率）（2025-2032）

• 市場概覽
• 製藥
• 病人自控鎮痛泵
• 神經阻斷
• 脂質體Bupivacaine
• 外科手術

膝蓋腫脹治療市場規模（按藥物療法和複合年成長率） (2025-2032)

• 市場概覽
• 鴉片類藥物
• 皮質類固醇
• 其他

膝關節腫脹治療市場規模（按手術類型和複合年成長率） (2025-2032)

• 市場概覽
• 關節穿刺術
• 關節鏡
• 膝關節關節重建
  • 全膝關節關節重建
  • 單髁膝關節關節重建
  • 其他

膝蓋腫脹治療市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 醫院
• 指定診所
• 門診手術中心
• 其他

膝關節腫脹治療市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Stryker Corporation（USA）
• Ossur（Iceland）
• Smith & Nephew（United Kingdom）
• Zimmer Biomet（USA）
• Arthrex（USA）
• DJO Global（USA）
• Medacta International（Switzerland）
• B. Braun Melsungen（Germany）
• Exactech（USA）
• Wright Medical Group（USA）
• Corin Group（United Kingdom）
• MicroPort Orthopedics（China）
• Aesculap Implant Systems（Germany）
• Tornier NV（Netherlands）
• Bioventus（USA）
• Pfizer（USA）
• Novartis（Switzerland）

結論和建議

Swollen Knee Treatment Market size was valued at USD 2.09 billion in 2023 and is poised to grow from USD 2.18 billion in 2024 to USD 3.11 billion by 2032, growing at a CAGR of 4.5% during the forecast period (2025-2032).

The swollen knee treatment market is likely to encounter growth challenges stemming from a noticeable trend towards non-surgical healthcare solutions. Patients are increasingly favoring therapeutic and preparatory treatments over traditional surgical options, demonstrating a shift towards minimally invasive and non-invasive approaches. Heightened awareness of the potential side effects and complications associated with surgical treatments, including knee arthroplasty, is driving this change in patient preferences. As individuals become more educated about the risks of surgical procedures, they are actively seeking alternative methods that provide similar effectiveness with less invasiveness and quicker recovery times. This evolving landscape necessitates a reevaluation of market strategies to align with the patients' preferences for safer and more conservative treatment options.

Top-down and bottom-up approaches were used to estimate and validate the size of the Swollen Knee Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Swollen Knee Treatment Market Segments Analysis

Global Swollen Knee Treatment Market is segmented by Type, Medications, Surgery, End User and region. Based on Type, the market is segmented into Medications, Patient-controlled Analgesia Pumps, Nerve Blocks, Liposomal Bupivacaine and Surgery. Based on Medications, the market is segmented into Opioids, Corticosteroids and Others. Based on Surgery, the market is segmented into Arthrocentesis, Arthroscopy and Knee Replacement. Based on End User, the market is segmented into Hospitals, Designated Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Swollen Knee Treatment Market

One of the key market drivers for the global swollen knee treatment market is the rising prevalence of knee-related disorders, such as osteoarthritis, rheumatoid arthritis, and sports injuries among the aging population. As the global demographic shifts towards an older population, the incidence of knee problems is increasing, necessitating effective treatment options. Additionally, lifestyle factors such as obesity and increased physical activity contribute to knee joint stress, leading to a higher demand for medical interventions. These factors, combined with advancements in treatment technologies and a growing emphasis on preventive care, are fueling the expansion of the swollen knee treatment market.

Restraints in the Swollen Knee Treatment Market

The Swollen Knee Treatment market faces significant restraints, primarily due to the financial barriers associated with advanced treatment options like knee replacement surgery. The total expenses for such procedures can be substantial, covering pre-operative evaluations, the surgery itself, post-operative care, and rehabilitation costs. These financial burdens can limit access for patients who may already be struggling with economic constraints, making it difficult for them to benefit from vital surgical interventions. Consequently, addressing these financial challenges is crucial to reducing healthcare disparities and ensuring equitable access to essential medical treatments for all individuals, regardless of their financial situation.

Market Trends of the Swollen Knee Treatment Market

The Swollen Knee Treatment market is witnessing a significant upward trend driven by advancements in medical device technology specifically tailored for knee-related solutions. Innovations in knee braces, supports, and orthotic implants are transforming treatment approaches for various orthopedic conditions, resulting in enhanced patient comfort and therapeutic outcomes. These state-of-the-art devices offer targeted support, stability, and optimal alignment, catering to a diverse range of knee issues, from acute injuries to chronic ailments. This continuous evolution not only enriches the treatment landscape but also empowers healthcare professionals to customize interventions, thereby meeting individual patient needs and enhancing the overall quality of care in the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Swollen Knee Treatment Market Size by Type & CAGR (2025-2032)

• Market Overview
• Medications
• Patient-controlled Analgesia Pumps
• Nerve Blocks
• Liposomal Bupivacaine
• Surgery

Global Swollen Knee Treatment Market Size by Medications & CAGR (2025-2032)

• Market Overview
• Opioids
• Corticosteroids
• Others

Global Swollen Knee Treatment Market Size by Surgery & CAGR (2025-2032)

• Market Overview
• Arthrocentesis
• Arthroscopy
• Knee Replacement
  • Total Knee Replacement
  • Unicompartmental Knee Replacement
  • Others

Global Swollen Knee Treatment Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Designated Clinics
• Ambulatory Surgical Centers
• Others

Global Swollen Knee Treatment Market Size & CAGR (2025-2032)

• North America (Type, Medications, Surgery, End User)
  • US
  • Canada
• Europe (Type, Medications, Surgery, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Medications, Surgery, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Medications, Surgery, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Medications, Surgery, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ossur (Iceland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DJO Global (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medacta International (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exactech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wright Medical Group (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corin Group (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Orthopedics (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aesculap Implant Systems (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tornier N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations